End Of An Accelerated Approval Odyssey: Covis Agrees To Withdraw Makena But Seeks 21-Week ‘Wind-Down’

Covis says it respects advisory committee vote at October public hearing favoring withdrawal; proposal comes four years after failure of the PROLONG confirmatory trial to confirm clinical benefit in preventing preterm birth.

Brick wall
Covis acknowledges the end of the road for Makena, but seeks a 21-week reprieve. • Source: Shutterstock

More from Post-Marketing Regulation & Studies

More from Product Reviews